Overview

SOMATULINE Autogel 90 mg IN DUMPING SYNDROME

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if Somatuline autogel 90 mg is effective in the treatment of dumping syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Collaborator:
Ipsen
Treatments:
Angiopeptin
Lanreotide
Somatostatin